Carlos Araujo Preza
Pulmonary Disease · The Woodlands, TXNPI 1154372688
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $63,912 of the $75,769 with a category attached, or 84.4%. 23 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 36.3% of the total. Among pulmonary disease clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $315.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$28K
- Mylan Specialty L.p.$23K
- Mallinckrodt Enterprises LLC$17K
- Boehringer Ingelheim$3K
- Mallinckrodt Hospital Products Inc.$2K
- AstraZeneca$2K
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$63,91284%
- Travel & lodging$7,88810%
- Food & beverage$3,8945%
- Education$760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 60 | $27,506 |
| Mylan Specialty L.p. | 49 | $23,111 |
| Mallinckrodt Enterprises LLC | 16 | $16,944 |
| Boehringer Ingelheim | 24 | $2,568 |
| Mallinckrodt Hospital Products Inc. | 5 | $2,220 |
| AstraZeneca | 6 | $2,107 |
| Actelion Pharmaceuticals US, Inc. | 10 | $238 |
| Philips North America LLC | 20 | $210 |
| GSK | 10 | $182 |
| Merck | 12 | $148 |
| Insmed, Inc. | 4 | $74 |
| Electromed, Inc. | 5 | $73 |
| Sanofi | 4 | $72 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Johnson & Johnson | 1 | $67 |
| Eisai Inc. | 3 | $56 |
| Bayer | 1 | $24 |
| Grifols USA, LLC | 1 | $21 |
| Gilead | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
| Circassia Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LONHALA MAGNAIR$26,490
- Yupelri$22,553
- ACTHAR$18,925
- SYMBICORT$2,000
- APTIOM$169
How this compares
$75,769 in reported general payments places this provider in the 90th percentile of 904 pulmonary disease providers in Texas.
Other pulmonary disease in The Woodlands
- Jefy MathewThe Woodlands$318K
- Hammad QureshiThe Woodlands$84K
- Antonio AnzuetoSan Antonio$1.8M
- Diego Maselli CaceresSan Antonio$1.5M
- Nicola HananiaHouston$1.3M
- Juan IribarrenBeaumont$915K
- William CalhounGalveston$568K
- David MarksSan Antonio$453K
- Sandeep SahayHouston$378K
- Rodolfo Estrada AnzuetoSan Antonio$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.